Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Case Western Reserve University
Cleveland, Ohio
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 130
Name | Type | Company | Disclosed Value | Year Filed |
---|---|---|---|---|
Anant Madabhushi | Conflict of Interest | Inspirata, Inc. | $100,000 - $149,999 | 2018 |
Anant Madabhushi | Conflict of Interest | Inspirata | $100,000 - $149,999 | 2018 |
Anant Madabhushi | Conflict of Interest | Inspirata, Inc. | $100,000 - $149,999 | 2016 |
Krzysztof Palczewski | Conflict of Interest | Polgenix | $80,000 - $99,999 | 2015 |
Krzysztof Palczewski | Conflict of Interest | Polgenix | $80,000 - $99,999 | 2015 |
Michael Weiss | Conflict of Interest | Thermalin Diabetes, LLC | $60,000 - $79,999 | 2017 |
Shridar Ganesan | Conflict of Interest | Inspirata, Inc. | $60,000 - $79,999 | 2017 |
Michael Konstan | Conflict of Interest | Vertex Pharmaceuticals | $40,000 - $59,999 | 2016 |
Jonathan Stamler | Conflict of Interest | Nivalis Therapeutics, Inc. | $20,000 - $39,999 | 2016 |
Stefan Gravenstein | Conflict of Interest | Sanofi Pasteur | $20,000 - $39,999 | 2018 |
Stefan Gravenstein | Conflict of Interest | Sanofi Pasteur | $20,000 - $39,999 | 2018 |
Stanton Gerson | Conflict of Interest | Tracon Therapeutics | $20,000 - $39,999 | 2019 |
Stanton Gerson | Conflict of Interest | Tracon Therapeutics | $20,000 - $39,999 | 2019 |
Mark Chance | Conflict of Interest | NEOProteomics, Inc. | $20,000 - $39,999 | 2017 |
Derek Abbott | Conflict of Interest | Oncodesign Biotechnology | $10,000 - $19,999 | 2016 |
Stefan Gravenstein | Conflict of Interest | Seqirus | $10,000 - $19,999 | 2019 |
Claudio Soto | Conflict of Interest | Amprion, Inc. | $10,000 - $19,999 | 2017 |
David Wilson | Conflict of Interest | BioInvision | $10,000 - $19,999 | 2013 |
Stanton Gerson | Conflict of Interest | Celgene Corporation | $10,000 - $19,999 | 2014 |
Nelson Phillips | Conflict of Interest | Thermalin Diabetes, LLC | $5,000 - $9,999 | 2017 |
Stanton Gerson | Conflict of Interest | Lentigen Corporation | $5,000 - $9,999 | 2019 |
Orville Kolterman | Conflict of Interest | diaVacs, Inc | $5,000 - $9,999 | 2015 |
Yogen Saunthararajah | Conflict of Interest | EpiDestiny, LLC/ DeNovo Therapeutics | $5,000 - $9,999 | 2019 |
Michael Weiss | Conflict of Interest | Thermalin Diabetes, LLC | $0 - $4,999 | 2017 |
Orlando Simonetti | Conflict of Interest | EXCMR, Inc | $0 - $4,999 | 2017 |
Yogen Saunthararajah | Conflict of Interest | EpiDestiny, LLC / DeNovo Therapies, LLC | $0 - $4,999 | 2017 |
Jonathan Stamler | Conflict of Interest | Novartis Institutes for Biomedical Research | 2016 | |
Mark Chance | Conflict of Interest | NEOProteomics, Inc. | 2017 | |
Anant Madabhushi | Conflict of Interest | Inspirata, Inc. | 2016 | |
Krzysztof Palczewski | Conflict of Interest | Polgenix | 2015 | |
Mark Chance | Conflict of Interest | NEOProteomics, Inc. | 2017 | |
Anant Madabhushi | Conflict of Interest | Inspirata, Inc. | 2016 | |
Anant Madabhushi | Conflict of Interest | Inspirata | 2018 | |
James Reynolds | Conflict of Interest | Novartis Institutes for Biomedical Research | 2016 | |
Benjamin Gaston | Conflict of Interest | Airbase Therapeutics, LLC | 2016 | |
Keviv Cooper | Conflict of Interest | Fluence Therapeutics | 2013 | |
Jonathan Stamler | Conflict of Interest | Nivalis Therapeutics, Inc. | 2016 | |
Michael Feldman | Conflict of Interest | Inspirata Inc. | 2016 | |
Zheng-Rong Lu | Conflict of Interest | Cleveland Theranostics, LLC | 2017 | |
John Chae | Conflict of Interest | SPR Therapeutics | 2018 | |
John Chae | Conflict of Interest | SPR Therapeutics | 2018 | |
Joseph Willis | Conflict of Interest | Lucid Diagnostics | 2018 | |
John Chae | Conflict of Interest | SPR Therapeutics | 2018 | |
Joseph Willis | Conflict of Interest | Lucid Diagnostics | 2018 | |
Joseph Willis | Conflict of Interest | Lucid Diagnostics | 2018 | |
John Chae | Conflict of Interest | SPR Therapeutics | 2018 | |
John Chae | Conflict of Interest | SPR Therapeutics | 2018 | |
Joseph Willis | Conflict of Interest | Lucid Diagnostics | 2018 | |
Zheng-Rong Lu | Conflict of Interest | Cleveland Theranostics, LLC | 2017 | |
Krzysztof Palczewski | Conflict of Interest | Polgenix | 2015 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.